Does metabolic syndrome influence short and long term durability of carotid endarterectomy and stenting?
<br/><strong>Aims: </strong>The metabolic syndrome (MetS) is composed of a cluster of related cardiovascular risk factors. The aim of the present study was to determine how MetS contributes to short‐ (30‐day) and long‐term complications and restenosis after carotid endarterectomy (...
Автори: | Casana, R, Malloggi, C, Tolva, V, Odero, A, Bulbulia, R, Halliday, A, Silani, V |
---|---|
Формат: | Journal article |
Мова: | English |
Опубліковано: |
Wiley
2018
|
Схожі ресурси
Схожі ресурси
-
Is diabetes a marker of higher risk after carotid revascularization? Experience from a single centre
за авторством: Casana, R, та інші
Опубліковано: (2018) -
Antiplatelet therapy in carotid artery stenting and carotid endarterectomy in the asymptomatic carotid surgery trial-2
за авторством: Huibers, A, та інші
Опубліковано: (2015) -
Ocular defects as surrogate end-points in trials comparing carotid endarterectomy and stenting.
за авторством: Giannoukas, A, та інші
Опубліковано: (2014) -
The Asymptomatic Carotid Surgery Trial-2 (ACST-2): An ongoing randomised trial comparing carotid endarterectomy with carotid artery stenting to prevent stroke
за авторством: Bulbulia, R, та інші
Опубліковано: (2017) -
Meta-analysis of the procedural risks of carotid endarterectomy and carotid artery stenting over time
за авторством: Lokuge, K, та інші
Опубліковано: (2017)